DCF — BEEBE MEDICAL CENTER
Enterprise Value: $-169.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-169.0M
Enterprise Value
$-69.0M
PV of Cash Flows
$-100.0M
PV of Terminal Value
$-161.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $566.2M | $-2.1M | -0.0% | $-26.0M | $-23.7M |
| Year 2 | $583.2M | $3.7M | 1.0% | $-21.0M | $-17.3M |
| Year 3 | $600.7M | $9.8M | 2.0% | $-15.6M | $-11.7M |
| Year 4 | $618.7M | $13.2M | 2.0% | $-13.0M | $-8.9M |
| Year 5 | $637.3M | $15.2M | 2.0% | $-11.8M | $-7.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-169.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$549.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.008665735570316009
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5